Report Detail
Global Neuromyelitis Optica Drug Market Growth 2019-2024
- RnM2872381 |
- 04 February, 2019 |
- Global |
- 167 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.
Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
In the last several years, global market of Neuromyelitis Optica Drug developed with the production growth rate about 4%. In 2015 global capacity of Neuromyelitis Optica Drug is more than 9100 K units.
North America is the largest supplier of Neuromyelitis Optica Drug, with a production market share of 59.3% and a consumption market share of 18.7%.
Europe is the second largest supplier of Neuromyelitis Optica Drug, following North America with the production market share of 25% and the consumption market share of 27%. Asia (Ex China) is another important market of Neuromyelitis Optica Drug, enjoying 31.8% sales market share.
According to this study, over the next five years the Neuromyelitis Optica Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neuromyelitis Optica Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromyelitis Optica Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Neuromyelitis Optica Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Glucocorticoids
Immunoglobulin
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Acute attack
Remission prophylactic treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
FRESENIUS
TEVA
SANDOZ
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Neuromyelitis Optica Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Neuromyelitis Optica Drug market by identifying its various subsegments.
Focuses on the key global Neuromyelitis Optica Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neuromyelitis Optica Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neuromyelitis Optica Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Neuromyelitis Optica Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Neuromyelitis Optica Drug Consumption 2014-2024
- 2.1.2 Neuromyelitis Optica Drug Consumption CAGR by Region
- 2.2 Neuromyelitis Optica Drug Segment by Type
- 2.2.1 Glucocorticoids
- 2.2.2 Immunoglobulin
- 2.3 Neuromyelitis Optica Drug Consumption by Type
- 2.3.1 Global Neuromyelitis Optica Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Neuromyelitis Optica Drug Sale Price by Type (2014-2019)
- 2.4 Neuromyelitis Optica Drug Segment by Application
- 2.4.1 Acute attack
- 2.4.2 Remission prophylactic treatment
- 2.5 Neuromyelitis Optica Drug Consumption by Application
- 2.5.1 Global Neuromyelitis Optica Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Neuromyelitis Optica Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Neuromyelitis Optica Drug Sale Price by Application (2014-2019)
3 Global Neuromyelitis Optica Drug by Players
- 3.1 Global Neuromyelitis Optica Drug Sales Market Share by Players
- 3.1.1 Global Neuromyelitis Optica Drug Sales by Players (2017-2019)
- 3.1.2 Global Neuromyelitis Optica Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Neuromyelitis Optica Drug Revenue Market Share by Players
- 3.2.1 Global Neuromyelitis Optica Drug Revenue by Players (2017-2019)
- 3.2.2 Global Neuromyelitis Optica Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Neuromyelitis Optica Drug Sale Price by Players
- 3.4 Global Neuromyelitis Optica Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Neuromyelitis Optica Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Neuromyelitis Optica Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Neuromyelitis Optica Drug by Regions
- 4.1 Neuromyelitis Optica Drug by Regions
- 4.1.1 Global Neuromyelitis Optica Drug Consumption by Regions
- 4.1.2 Global Neuromyelitis Optica Drug Value by Regions
- 4.2 Americas Neuromyelitis Optica Drug Consumption Growth
- 4.3 APAC Neuromyelitis Optica Drug Consumption Growth
- 4.4 Europe Neuromyelitis Optica Drug Consumption Growth
- 4.5 Middle East & Africa Neuromyelitis Optica Drug Consumption Growth
5 Americas
- 5.1 Americas Neuromyelitis Optica Drug Consumption by Countries
- 5.1.1 Americas Neuromyelitis Optica Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Neuromyelitis Optica Drug Value by Countries (2014-2019)
- 5.2 Americas Neuromyelitis Optica Drug Consumption by Type
- 5.3 Americas Neuromyelitis Optica Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Neuromyelitis Optica Drug Consumption by Countries
- 6.1.1 APAC Neuromyelitis Optica Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Neuromyelitis Optica Drug Value by Countries (2014-2019)
- 6.2 APAC Neuromyelitis Optica Drug Consumption by Type
- 6.3 APAC Neuromyelitis Optica Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Neuromyelitis Optica Drug by Countries
- 7.1.1 Europe Neuromyelitis Optica Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Neuromyelitis Optica Drug Value by Countries (2014-2019)
- 7.2 Europe Neuromyelitis Optica Drug Consumption by Type
- 7.3 Europe Neuromyelitis Optica Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Neuromyelitis Optica Drug by Countries
- 8.1.1 Middle East & Africa Neuromyelitis Optica Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Neuromyelitis Optica Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Neuromyelitis Optica Drug Consumption by Type
- 8.3 Middle East & Africa Neuromyelitis Optica Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Neuromyelitis Optica Drug Distributors
- 10.3 Neuromyelitis Optica Drug Customer
11 Global Neuromyelitis Optica Drug Market Forecast
- 11.1 Global Neuromyelitis Optica Drug Consumption Forecast (2019-2024)
- 11.2 Global Neuromyelitis Optica Drug Forecast by Regions
- 11.2.1 Global Neuromyelitis Optica Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Neuromyelitis Optica Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Neuromyelitis Optica Drug Forecast by Type
- 11.8 Global Neuromyelitis Optica Drug Forecast by Application
12 Key Players Analysis
- 12.1 Pfizer
- 12.1.1 Company Details
- 12.1.2 Neuromyelitis Optica Drug Product Offered
- 12.1.3 Pfizer Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Pfizer News
- 12.2 FRESENIUS
- 12.2.1 Company Details
- 12.2.2 Neuromyelitis Optica Drug Product Offered
- 12.2.3 FRESENIUS Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 FRESENIUS News
- 12.3 TEVA
- 12.3.1 Company Details
- 12.3.2 Neuromyelitis Optica Drug Product Offered
- 12.3.3 TEVA Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 TEVA News
- 12.4 SANDOZ
- 12.4.1 Company Details
- 12.4.2 Neuromyelitis Optica Drug Product Offered
- 12.4.3 SANDOZ Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 SANDOZ News
- 12.5 Intas
- 12.5.1 Company Details
- 12.5.2 Neuromyelitis Optica Drug Product Offered
- 12.5.3 Intas Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Intas News
- 12.6 Gyjtrs
- 12.6.1 Company Details
- 12.6.2 Neuromyelitis Optica Drug Product Offered
- 12.6.3 Gyjtrs Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Gyjtrs News
- 12.7 NANG KUANG
- 12.7.1 Company Details
- 12.7.2 Neuromyelitis Optica Drug Product Offered
- 12.7.3 NANG KUANG Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 NANG KUANG News
- 12.8 Tianjin Kingyork
- 12.8.1 Company Details
- 12.8.2 Neuromyelitis Optica Drug Product Offered
- 12.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Tianjin Kingyork News
- 12.9 Baxter
- 12.9.1 Company Details
- 12.9.2 Neuromyelitis Optica Drug Product Offered
- 12.9.3 Baxter Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Baxter News
- 12.10 CSL
- 12.10.1 Company Details
- 12.10.2 Neuromyelitis Optica Drug Product Offered
- 12.10.3 CSL Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 CSL News
- 12.11 Grifols
- 12.12 Octapharma
- 12.13 CBOP
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Neuromyelitis Optica Drug . Industry analysis & Market Report on Neuromyelitis Optica Drug is a syndicated market report, published as Global Neuromyelitis Optica Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Neuromyelitis Optica Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
